Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophrenia

Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophrenia

<p>Abstract</p> <p>Background</p> <p>Although not recommended in treatment guidelines, previous studies have shown a frequent use of more than one antipsychotic agent among patients with schizophrenia. The main aims of the present study were to explore the antipsychotic...

Full description

Bibliographic Details
Main Authors:	Agartz Ingrid, Røssberg Jan I, Andreassen Ole A, Bolstad Albert, Melle Ingrid, Tanum Lars
Format:	Article
Language:	English
Published:	BMC 2011-08-01
Series:	BMC Psychiatry
Online Access:	http://www.biomedcentral.com/1471-244X/11/126

Similar Items

Neurocognitive decrements are present in intellectually superior schizophrenia
by: Anja eVaskinn, et al.
Published: (2014-05-01)

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
by: Petter Andreas Ringen, et al.
Published: (2019-09-01)

Sex differences in autonomic adverse effects related to antipsychotic treatment and associated hormone profiles
by: Ingrid T. Johansen, et al.
Published: (2024-01-01)

Exploring white matter microstructure and the impact of antipsychotics in adolescent-onset psychosis.
by: Claudia Barth, et al.
Published: (2020-01-01)

Correction: Risk Variant and Amygdala Activity in Bipolar Disorder, Schizophrenia and Healthy Controls.
by: Martin Tesli, et al.
Published: (2013-01-01)

The factor structure of social cognition in schizophrenia: Weak evidence for separable domains
by: Anja Vaskinn, et al.
Published: (2021-12-01)

CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls.
by: Martin Tesli, et al.
Published: (2013-01-01)

Association between a genetic variant in the serotonin transporter gene (<it>SLC6A4</it>) and suicidal behavior in patients with schizophrenia
by: Lindholm Carlström Eva, et al.
Published: (2012-05-01)

Perceived discrimination is associated with severity of positive and depression/anxiety symptoms in immigrants with psychosis: a cross-sectional study
by: Romm Kristin, et al.
Published: (2011-05-01)

The estrogen hypothesis of Schizophrenia implicates glucose metabolism: Association study in three independent samples
by: Timm Sally, et al.
Published: (2008-05-01)

Childhood Trauma in Persons With Schizophrenia and a History of Interpersonal Violence
by: Guttorm Breivik Storvestre, et al.
Published: (2020-05-01)

Childhood Trauma and Minimization/Denial in People with and without a Severe Mental Disorder
by: Chelsea Church, et al.
Published: (2017-08-01)

Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
by: Elina J. Reponen, et al.
Published: (2021-05-01)

Evidence for a possible association of neurotrophin receptor (NTRK-3) gene polymorphisms with hippocampal function and schizophrenia
by: Mona K. Otnæss, et al.
Published: (2009-06-01)

Medication Gaps and Antipsychotic Polypharmacy in Previously Hospitalized Schizophrenia Patients: An Electronic Cohort Study in Three Canadian Provinces
by: Evyn Peters, et al.
Published: (2022-06-01)

Apathy is associated with executive functioning in first episode psychosis
by: Agartz Ingrid, et al.
Published: (2009-01-01)

Contribution of oxytocin receptor polymorphisms to amygdala activation in schizophrenia spectrum disorders
by: Marit Haram, et al.
Published: (2016-11-01)

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
by: Cipriani, A, et al.
Published: (2009)

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
by: Barber, S, et al.
Published: (2017)

Combined use of antipsychotics and electroconvulsive therapy in theurapetically resistant schizophrenia
by: S. V. Sizov, et al.
Published: (2018-07-01)

Reduced load-dependent default mode network deactivation across executive tasks in schizophrenia spectrum disorders
by: Beathe Haatveit, et al.
Published: (2016-01-01)

Atypical antipsychotics in the treatment of schizophrenia
by: Swiss Medical Weekly
Published: (2003-02-01)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
by: Correll Christoph, et al.
Published: (2005-05-01)

Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients
by: Miloš Marković, et al.
Published: (2023-12-01)

Altered Brain Activation during Emotional Face Processing in Relation to Both Diagnosis and Polygenic Risk of Bipolar Disorder.
by: Martin Tesli, et al.
Published: (2015-01-01)

Childhood Trauma Is Nominally Associated With Elevated Cortisol Metabolism in Severe Mental Disorder
by: Monica Aas, et al.
Published: (2020-05-01)

The therapeutic relationship and adherence to antipsychotic medication in schizophrenia.
by: Rosemarie McCabe, et al.
Published: (2012-01-01)

Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study
by: Tack Jan, et al.
Published: (2011-03-01)

Clinical and cortical similarities identified between bipolar disorder I and schizophrenia: A multivariate approach
by: Kelly Rootes-Murdy, et al.
Published: (2022-11-01)

Biclustered Independent Component Analysis for Complex Biomarker and Subtype Identification from Structural Magnetic Resonance Images in Schizophrenia
by: Cota Navin Gupta, et al.
Published: (2017-09-01)

Treatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medication
by: Yang FD, et al.
Published: (2017-04-01)

Atypical antipsychotics in the treatment of schizophrenia - Reply
by: Geddes, J, et al.
Published: (2001)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
by: Hiroyuki Kamei
Published: (2022-11-01)

ADHERENCE TO ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA PATIENTS
by: Peter Pregelj
Published: (2009-01-01)

New atypical antipsychotics for schizophrenia: iloperidone
by: Silvio Caccia, et al.
Published: (2010-02-01)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
by: Correll Christoph U, et al.
Published: (2008-04-01)

Antipsychotic agents: efficacy and safety in schizophrenia
by: de Ara&uacute;jo AN, et al.
Published: (2012-11-01)

Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia – A 3-year follow-up
by: Chen-Chung Liu, et al.
Published: (2015-06-01)

The combination of long-acting injectable antipsychotics, a new key in resistant schizophrenia
by: M.F. Tascón Guerra, et al.
Published: (2022-06-01)

Schizophrenia treatment with a combination of two LAI antipsychotics: A case report
by: Marcin Jarosz, et al.
Published: (2022-09-01)